{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:24:50Z","timestamp":1791498290868,"version":"4.3.4"},"reference-count":16,"publisher":"Europa Digital & Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.4244\/eijv11i4a77","type":"journal-article","created":{"date-parts":[[2015,9,6]],"date-time":"2015-09-06T10:24:42Z","timestamp":1441535082000},"page":"376-379","source":"Crossref","is-referenced-by-count":1,"title":["Periprocedural oral anticoagulation during percutaneous coronary interventions: more evidence to fuel an uninterrupted debate"],"prefix":"10.4244","volume":"11","author":[{"given":"Konstantinos C.","family":"Koskinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-20159611030-0","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1160\/TH09-08-0580","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary intervention\/stenting.","volume":"103","author":"Lip GY.","year":"2010","journal-title":"Thromb Haemost."},{"key":"key-20159611030-1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4244\/EIJY14M06_07","article-title":"Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial.","volume":"11","author":"Dewilde WJ.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20159611030-2","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/01.CIR.103.16.2042","article-title":"Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.","volume":"103","author":"ten Berg JM.","year":"2001","journal-title":"Circulation."},{"key":"key-20159611030-3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ccd.21758","article-title":"Percutaneous coronary intervention in anticoagulated patients via radial artery access.","volume":"73","author":"Helft G.","year":"2009","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-20159611030-4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ccd.10595","article-title":"Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.","volume":"60","author":"Jessup DB.","year":"2003","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-20159611030-5","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1253\/circj.CJ-11-1206","article-title":"Heparin bridging vs. uninterrupted oral anticoagulation in patients with atrial fibrillation undergoing coronary artery stenting. Results from the AFCAS registry.","volume":"76","author":"Lahtela H.","year":"2012","journal-title":"Circ J."},{"key":"key-20159611030-6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/eurheartj\/ehn099","article-title":"Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.","volume":"29","author":"Karjalainen PP.","year":"2008","journal-title":"Eur Heart J."},{"key":"key-20159611030-7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002053","article-title":"Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.","volume":"8","author":"Koskinas KC.","year":"2015 May 8","journal-title":"Circ Cardiovasc Interv."},{"key":"key-20159611030-8","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.","volume":"385","author":"Valgimigli M.","year":"2015","journal-title":"Lancet."},{"key":"key-20159611030-9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/ccd.22527","article-title":"Radial versus femoral access for orally anticoagulated patients.","volume":"76","author":"Ziakas AG.","year":"2010","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-20159611030-10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ahj.2014.06.016","article-title":"Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin.","volume":"168","author":"Baker NC.","year":"2014","journal-title":"Am Heart J."},{"key":"key-20159611030-11","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","article-title":"Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.","volume":"126","author":"Siegal D.","year":"2012","journal-title":"Circulation."},{"key":"key-20159611030-12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.114.011777","article-title":"Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).","volume":"131","author":"Steinberg BA.","year":"2015","journal-title":"Circulation."},{"key":"key-20159611030-13","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation.","volume":"368","author":"Birnie DH.","year":"2013","journal-title":"N Engl J Med."},{"key":"key-20159611030-14","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation.","volume":"Epub AOP","author":"Douketis JD.","year":"2015 Jun 22","journal-title":"N Engl J Med."},{"key":"key-20159611030-15","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions.","volume":"35","author":"Lip GY.","year":"2014","journal-title":"Eur Heart J."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T19:02:28Z","timestamp":1498244548000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/87th_issue\/77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["EIJV11I4A77"],"URL":"https:\/\/doi.org\/10.4244\/eijv11i4a77","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}